StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
ELABPMGC Holdings Inc.
stockpulse.co.kr
Nasdaq
$2.71▲ 1.72%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $12.3MShares out 4.5M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

30
  • 2d agoAfter-hours26.10.23 05:08
    SCHEDULE 13D/AOwnership#●●●

    PMGC Holdings Inc.

    NorthStrive Acquisition Corp I has confirmed the forfeiture of 629,998 initial shares held by initial shareholders following the expiration of the unexercised over-allotment option. This action adjusts the total holdings of the initial shareholders to 4,200,000 shares to comply with the ownership percentage requirements stipulated in the underwriting agreement.…more

    $2.71+1.72%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.29After-hours26.09.30 08:58
    SCHEDULE 13DOwnership

    PMGC Holdings Inc.

    PMGC Holdings Inc., as the sole member of NorthStrive Sponsor I LLC, amended and restated the company's operating agreement on September 25, 2026. Through this agreement, PMGC Holdings solidified its control over the 2,728,070 Class A ordinary shares of NorthStrive Acquisition Corp I. held by the entity and redefined the management and operational authority.…more

    $2.71+1.72%vs prev close
    View filingShare
  • 9.18Pre-market26.09.18 21:01
    8-KKey event

    PMGC Holdings Inc.

    PMGC Holdings has entered into a payment agreement with Longevity Health Holdings to secure royalty payments from the January 2025 sale of its Elevai Skincare business. Under the terms, the company will receive scheduled monthly cash payments of at least $10,000, including a $94,937 balance for 2025, through August 2031. This agreement provides non-dilutive, recurring cash flow to support the company's growth strategy.…more

    $2.71+1.72%vs prev close
    View filingShare

29 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 10.8Regular26.10.08 23:01
    #●●●

    PMGC Holdings Announces Rebranding to NorthStrive

    PMGC Holdings has entered into a trademark license agreement to adopt the NorthStrive brand and plans to formally change its legal name within six months. This rebranding initiative aims to unify the company's corporate identity but does not carry immediate financial impact.…more

    $2.71+1.72%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    Read sourceShareGlobeNewswire
  • 10.1Pre-market26.10.01 21:05

    ●●●●●●●● ●●●●● ●●●●●●

    PMGC Holdings announced it is the sponsor of the $100 million SPAC NorthStrive Acquisition Corp I, holding a 21.4% stake. This disclosure of ownership structure does not provide immediate material impact on the company's stock price.…more

    $2.71+1.72%vs prev close
    ShareBenzinga
  • 9.29Pre-market26.09.29 20:33

    ●●●●●●●● ●●●●● ●●●●●●

    NorthStrive Biosciences has entered into an agreement with Charles River Laboratories to conduct analytical characterization for its EL-22 and EL-32 engineered probiotic candidates. This collaboration focuses on strengthening manufacturing and quality control frameworks as the programs move toward IND-enabling development.…more

    $2.71+1.72%vs prev close
    Read sourceShareGlobeNewswire

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →